Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.29 USD
−10.28 M USD
1.30 M USD
11.34 M
About TherapeuticsMD, Inc.
Sector
CEO
Marlan D. Walker
Headquarters
Boca Raton
Website
Founded
1907
FIGI
BBG000LKB954
TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TXMD is 1.11 USD — it has increased by 1.83% in the past 24 hours. Watch TherapeuticsMD, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TherapeuticsMD, Inc. stocks are traded under the ticker TXMD.
TXMD stock has fallen by −10.48% compared to the previous week, the month change is a −19.57% fall, over the last year TherapeuticsMD, Inc. has showed a −53.36% decrease.
TXMD reached its all-time high on Feb 2, 2010 with the price of 8,000.00 USD, and its all-time low was 1.05 USD and was reached on Dec 19, 2024. View more price dynamics on TXMD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TXMD stock is 7.41% volatile and has beta coefficient of 1.10. Track TherapeuticsMD, Inc. stock price on the chart and check out the list of the most volatile stocks — is TherapeuticsMD, Inc. there?
Today TherapeuticsMD, Inc. has the market capitalization of 12.80 M, it has decreased by −8.80% over the last week.
Yes, you can track TherapeuticsMD, Inc. financials in yearly and quarterly reports right on TradingView.
TherapeuticsMD, Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
TXMD earnings for the last quarter are −0.05 USD per share, whereas the estimation was 0.04 USD resulting in a −225.00% surprise. The estimated earnings for the next quarter are 0.04 USD per share. See more details about TherapeuticsMD, Inc. earnings.
TXMD net income for the last quarter is −609.00 K USD, while the quarter before that showed −1.09 M USD of net income which accounts for 44.13% change. Track more TherapeuticsMD, Inc. financial stats to get the full picture.
No, TXMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 1.00 employees. See our rating of the largest employees — is TherapeuticsMD, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TherapeuticsMD, Inc. EBITDA is −3.75 M USD, and current EBITDA margin is −583.79%. See more stats in TherapeuticsMD, Inc. financial statements.
Like other stocks, TXMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TherapeuticsMD, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TherapeuticsMD, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TherapeuticsMD, Inc. stock shows the sell signal. See more of TherapeuticsMD, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.